Antimicrobial composition
View Patent ↗An antimicrobial composition is provided. The antimicrobial composition has broad antimicrobial efficacy in a format convenient for no-rinse application to the skin. The composition dries quickly, leaves the skin smooth, comfortable and adequately moisturized. A method of making the antimicrobial composition, a method of sanitizing skin using the antimicrobial composition, and a foam dispenser comprising the antimicrobial composition are also provided.
1. An antimicrobial composition comprising:
(a) approximately 0.1 wt. % benzalkonium chloride,
(b) approximately 0.12 wt. % dihydroxypropyl PEG-5 linoleammonium chloride,
(c) approximately 0.1 wt. % glycereth-2 cocoate,
(d) approximately 0.9 wt. % behentrimonium chloride,
(e) approximately 0.06 wt. % dihydroxyethyl cocamine oxide, and
(f) water.
2. An antimicrobial composition comprising:
(a) approximately 0.1 wt. % benzalkonium chloride,
(b) approximately 0.12 wt. % dihydroxypropyl PEG-5 linoleammonium chloride,
(c) approximately 0.1 wt. % glycereth-2 cocoate,
(d) approximately 0.9 wt. % behentrimonium chloride,
(e) approximately 0.06 wt. % dihydroxyethyl cocamine oxide,
(f) approximately 0.05 wt. % hydroxypropyl methylcellulose,
(g) approximately 1 wt. % butylenes glycol, and
(h) water.
3. An antimicrobial composition comprising:
(a) from approximately 0.1% to approximately 0.13% benzalkonium chloride
(b) from approximately 0.05% to approximately 0.5% dihydroxypropyl PEG-5 linoleammonium chloride;
(c) from approximately 0.05% to approximately 0.5% dihydroxyethyl cocamine oxide
(d) from approximately 0.05% to approximately 0.5% glycereth-2 cocoate; and
(e) from approximately 0.05% to approximately 0.5% behentrimonium chloride, wherein the composition does not contain alcohol.
4. A method of sanitizing skin comprising contacting a skin surface with the antimicrobial composition of claim 3 .
5. A foaming dispenser comprising the antimicrobial composition of claim 3 .
6. The antimicrobial composition of claim 3 , comprising:
(a) approximately 0.1% benzalkonium chloride
(b) approximately 0.3% dihydroxypropyl PEG-5 linoleammonium chloride
(c) approximately 0.1% dihydroxyethyl cocamine oxide
(d) approximately 0.1% glycereth-2 cocoate, and
(e) approximately 0.1% behentrimonium chloride.
7. The antimicrobial composition of claim 3 , wherein the benzalkonium chloride is a homolog having the following formula:
wherein R is a C 12 -C 18 alkyl side chain, wherein a homolog distribution is not less than 70% C 12 and C 14 combined.
8. The antimicrobial composition of claim 6 , wherein the benzalkonium chloride is a homolog having the following formula:
wherein R is a C 12 -C 18 alkyl side chain, wherein a homolog distribution is not less than 70% C 12 and C 14 combined.
9. The antimicrobial composition of claim 3 , wherein a homolog distribution is not less than 70% C 12 and C 14 combined.
10. The antimicrobial composition of claim 6 , wherein a homolog distribution is not less than 70% C 12 and C 14 combined.
11. The antimicrobial composition of claim 3 , wherein a homolog distribution is less than 90% combined C 12 and C 14 homologs.
12. The antimicrobial composition of claim 6 , wherein a homolog distribution is less than 90% combined C 12 and C 14 homologs.
13. The antimicrobial composition of claim 3 , wherein a homolog distribution is approximately 67% C 12 , approximately 25% C 14 , approximately 7% C 16 , and 1% C 18 .
14. The antimicrobial composition of claim 6 , wherein a homolog distribution is approximately 67% C 12 , approximately 25% C 14 , approximately 7% C 16 , and 1% C 18 .
15. An antimicrobial composition comprising:
(a) from approximately 0.01% to approximately 2.0% of an antimicrobial agent, wherein the anti-microbial agent is selected from the group consisting of benzalkonium chloride and benzethonium chloride;
(b) from approximately 0.01% to approximately 2.0% of dihydroxypropyl PEG-5 linoleammonium chloride;
(c) from approximately 0.05% to approximately 0.5% of dihydroxyethyl cocamine oxide;
(d) from approximately 0.01% to approximately 2.0% of behentrimonium chloride; and
(e) from approximately 0.05% to approximately 0.5% glycereth-2 cocoate wherein the composition does not contain alcohol.
16. The antimicrobial composition of claim 15 , comprising:
(a) from approximately 0.1% to approximately 0.13% benzalkonium chloride
(b) from approximately 0.05% to approximately 0.5% dihydroxypropyl PEG-5 linoleammonium chloride;
(c) from approximately 0.05% to approximately 0.5% dihydroxyethyl cocamine oxide
(d) from approximately 0.05% to approximately 0.5% glycereth-2 cocoate; and
(e) from approximately 0.05% to approximately 0.5% behentrimonium chloride.
17. The antimicrobial composition of claim 15 , wherein the benzalkonium chloride is a homolog having the following formula:
wherein R is a C 12 -C 18 alkyl side chain, wherein a homolog distribution is not less than 70% C 12 and C 14 combined.
18. The antimicrobial composition of claim 15 , wherein the composition inactivates greater than 99.9% of a microbe, within approximately 15 seconds from the time of application to an area containing microbes.